Please provide your email address to receive an email when new articles are posted on . The European Medicines Agency has recommended the approval of Dupixent in the European Union for adults with ...
US, European regulators set principles for 'good AI practice' in drug development The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and ...
NEWARK, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic ...
Learn how to develop and obtain market authorisation in the EU for medicinal products, therapies and medical devices intended for human use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results